Targeted Cancer Therapy

Wednesday, January 1, 2025, 8:00 AM - Wednesday, December 31, 2025, 11:59 PM


This recorded 1-hr educational activity is presented by Oncology Pharmacist, Rawmina Keshavarzi PharmD. The target audience is Advance Practice Providers and Nurses. It provides a review and updates on cancer targeted therapy in solid tumors and its relevance to clinical practice. By the end of the educational activity learners will be able to describe the mechanism of action and common toxicities of various targeted therapy classes.

1. Review the history of targeted cancer therapies.
2. Discuss the mechanism of action and common toxicities of various targeted therapy classes.
3. Understand key distinctions between drugs within each therapeutic class.
4. Identify main points relevant to daily clinical practice.
5. Describe how implicit bias can impact patient care.

Registration Fee

SHC Employee: $10.00

Regular Fee: $15.00

Please be sure to pay with a credit card, if payment is not received, your registration will be incomplete and you will not be registered for the course.

ANCC - American Nurses Credentialing Center contact hour(s) (1.00 hours), ANCC Pharma- American Nurse Credentialing Center Pharma contact hour(s) (1.00 hours), CA BRN - California Board of Registered Nurses contact hour(s) (1.00 hours), General Attendance (1.00 hours)

1. Stanford Health Care is provider approved by the California Board of Registered Nursing (BRN).  Provider Number CEP12165.
2. Stanford Health Care Center for Education, Research, and Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. *Neither SHC nor ANCC endorse any commercial products

 

©2025 by Stanford Health Care, Division of Patient Care Services.
All rights reserved. No audio or video taping allowed. We reserve the right to make program changes. All students must be registered, attend the entire course, and submit an evaluation after course completion to earn credit hours.

Mitigation of Relevant Financial Relationships

Stanford Health Care (SHC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.